Lung Cancer Chemotherapy for Radiation Oncologists

Lawrence H. Einhorn, John McClean, Kenneth Pennington, Phase II trial of daily oral VP-16 in refractory small cell lung cancer: a Hoosier Oncology Group study. Seminars in Oncology. ,vol. 17, pp. 32- 35 ,(1990) , 10.5555/URI:PII:009377549090069F

G. Riethmüller, B. Passlick, K. Pantel, J. R. Izbicki, O. Thetter, O. Karg, M. Angstwurm, S. Braun, Immunocytological Detection of Bone Marrow Micrometastasis in Operable Non-Small Cell Lung Cancer Cancer Research. ,vol. 53, pp. 1027- 1031 ,(1993)

J L Pujol, J Y Douillard, A Rivière, E Quoix, J L Lagrange, P Berthaud, M Bardonnet-Comte, V Polin, V Gautier, B Milleron, F Chomy, P Chomy, D Spaeth, T Le Chevalier, Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study. Journal of Clinical Oncology. ,vol. 15, pp. 2082- 2089 ,(1997) , 10.1200/JCO.1997.15.5.2082

Jean Klastersky, Jean-Paul Sculier, Hendrik Lacroix, Gérard Dabouis, Gérard Bureau, P Libert, Michel Richez, Pol Ravez, Guy Vandermoten, Jacques Thiriaux, None, A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861. Journal of Clinical Oncology. ,vol. 8, pp. 1556- 1562 ,(1990) , 10.1200/JCO.1990.8.9.1556

A J Wozniak, J J Crowley, S P Balcerzak, G R Weiss, C H Spiridonidis, L H Baker, K S Albain, K Kelly, S A Taylor, D R Gandara, R B Livingston, Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: A Southwest Oncology Group study Journal of Clinical Oncology. ,vol. 16, pp. 2459- 2465 ,(1998) , 10.1200/JCO.1998.16.7.2459

Frank V. Fossella, Russell DeVore, Ronald N. Kerr, Jeffrey Crawford, Ronald R. Natale, Frank Dunphy, Leonard Kalman, Vincent Miller, Jin Soo Lee, Melvin Moore, David Gandara, Daniel Karp, Everett Vokes, Mark Kris, Yong Kim, Francis Gamza, Luz Hammershaimb, , Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens Journal of Clinical Oncology. ,vol. 18, pp. 2354- 2362 ,(2000) , 10.1200/JCO.2000.18.12.2354

D C Ihde, J L Mulshine, B S Kramer, S M Steinberg, R I Linnoila, A F Gazdar, M Edison, R M Phelps, M Lesar, J C Phares, Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. Journal of Clinical Oncology. ,vol. 12, pp. 2022- 2034 ,(1994) , 10.1200/JCO.1994.12.10.2022

A.B. Sandler, J. Nemunaitis, C. Denham, J. von Pawel, Y. Cormier, U. Gatzemeier, K. Mattson, Ch. Manegold, M.C. Palmer, A. Gregor, B. Nguyen, C. Niyikiza, L.H. Einhorn, Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 18, pp. 122- 122 ,(2000) , 10.1200/JCO.2000.18.1.122

D Fichet, B Lebeau, P Allard, J Migueres, F Boita, C Chastang, Six vs twelve cycles for complete responders to chemotherapy in small cell lung cancer: definitive results of a randomized clinical trial. The "Petites Cellules" Group. European Respiratory Journal. ,vol. 5, pp. 286- 290 ,(1992)

W K Hong, C Nicaise, R Lawson, J A Maroun, R Comis, J Speer, D Luedke, M Hurtubise, V Lanzotti, J Goodlow, Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial of the Bristol Lung Cancer Study Group. Journal of Clinical Oncology. ,vol. 7, pp. 450- 456 ,(1989) , 10.1200/JCO.1989.7.4.450